We conclude that pharmacologic inhibition of MLK3 reduces the in vitro migratory capacity of breast cancer cells, but that it has no effect on either the frequency or size of breast cancer brain metastases, when tested in a preclinical mouse xenograft model. Here, MAP3K11 is linked to breast cancer.